[
  {
    "ts": null,
    "headline": "Does Regeneron’s Choppy 2025 Share Price Reflect Its Long Term Growth Potential?",
    "summary": "If you have ever wondered whether Regeneron Pharmaceuticals is a smart buy at around $718 a share, you are not alone; investors are trying to figure out if the current price really reflects its long term potential. The stock has been choppy lately, down 7.9% over the last week but still up 11.5% over the past month, leaving it only slightly positive year to date at 0.4% and modestly higher over five years with a 50.6% gain. Much of this volatility has been tied to shifting sentiment around...",
    "url": "https://finnhub.io/api/news?id=740cc93e8357fa6bc3aed40719bcf074e06c67778a1593fddeff25fd171cc492",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765055298,
      "headline": "Does Regeneron’s Choppy 2025 Share Price Reflect Its Long Term Growth Potential?",
      "id": 137726600,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "If you have ever wondered whether Regeneron Pharmaceuticals is a smart buy at around $718 a share, you are not alone; investors are trying to figure out if the current price really reflects its long term potential. The stock has been choppy lately, down 7.9% over the last week but still up 11.5% over the past month, leaving it only slightly positive year to date at 0.4% and modestly higher over five years with a 50.6% gain. Much of this volatility has been tied to shifting sentiment around...",
      "url": "https://finnhub.io/api/news?id=740cc93e8357fa6bc3aed40719bcf074e06c67778a1593fddeff25fd171cc492"
    }
  }
]